High‐Mobility Group Box‐1 and Liver Disease
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
High‐mobility group box‐1 (HMGB1) is a ubiquitous protein. While initially thought to be simply an architectural protein due to its DNA‐binding ability, evidence from the last decade suggests that HMGB1 is a key protein participating in the pathogenesis of acute liver injury and chronic liver disease. When it is passively released or actively secreted after injury, HMGB1 acts as a damage‐associated molecular pattern that communicates injury and inflammation to neighboring cells by the receptor for advanced glycation end products or toll‐like receptor 4, among others. In the setting of acute liver injury, HMGB1 participates in ischemia/reperfusion, sepsis, and drug‐induced liver injury. In the context of chronic liver disease, it has been implicated in alcoholic liver disease, liver fibrosis, nonalcoholic steatohepatitis, and hepatocellular carcinoma. Recently, specific posttranslational modifications have been identified that could condition the effects of the protein in the liver. Here, we provide a detailed review of how HMGB1 signaling participates in acute liver injury and chronic liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · cited 4×
“(12,79) Both in vitro induction of apoptosis(80) and injection of mice with the Fas agonistic Jo2 antibody(81) induce HMGB1 release; yet, cells undergoing apoptosis induce negligible inflammation in the surrounding tissue(82) as HMGB1 remains bound to DNA in apoptotic cells.(12) Active secretion of HMGB1 by secretory…”
BackgroundInfluentialRAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372 · cited 1×
“HMGB1 binds multiple receptors, including RAGE, toll-like receptors (TLRs) 2/4/9, Mac-1, syndecan-1, phosphacan protein-tyrosine phosphatase-ζ/β, and clusters of differentiation 24.(11,90‒93) Due to the dominant role of RAGE and TLR4 in liver disease, we focus on these two receptors.”
BackgroundThe Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151 · cited 3×
“HMGB1 is a specific and saturable ligand that binds with high affinity to RAGE.(94) The expression of RAGE is mediated, at least in part, through an autoregulatory loop whereby the interaction of HMGB1 with RAGE leads to nuclear factor κB (NFκB) and Sp1-dependent transactivation of the advanced glycosylation end-produ…”
BackgroundInfluentialHMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., & Yang, H. (2006) · Shock · doi:10.1097/01.shk.0000225404.51320.82 · Cited by 832 · cited 1×
“HMGB1 binds multiple receptors, including RAGE, toll-like receptors (TLRs) 2/4/9, Mac-1, syndecan-1, phosphacan protein-tyrosine phosphatase-ζ/β, and clusters of differentiation 24.(11,90‒93) Due to the dominant role of RAGE and TLR4 in liver disease, we focus on these two receptors.”
BackgroundCD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses
Chen, G.-Y., Tang, J., Zheng, P., & Liu, Y. (2009) · Science · doi:10.1126/science.1168988 · Cited by 786 · cited 1×
“HMGB1 binds multiple receptors, including RAGE, toll-like receptors (TLRs) 2/4/9, Mac-1, syndecan-1, phosphacan protein-tyrosine phosphatase-ζ/β, and clusters of differentiation 24.(11,90‒93) Due to the dominant role of RAGE and TLR4 in liver disease, we focus on these two receptors.”
BackgroundHigh‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
Bianchi, M. E., & Manfredi, A. A. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00574.x · Cited by 600 · cited 1×
“HMGB1 binds multiple receptors, including RAGE, toll-like receptors (TLRs) 2/4/9, Mac-1, syndecan-1, phosphacan protein-tyrosine phosphatase-ζ/β, and clusters of differentiation 24.(11,90‒93) Due to the dominant role of RAGE and TLR4 in liver disease, we focus on these two receptors.”
BackgroundThe extracellular release of HMGB1 during apoptotic cell death
Bell, C. W., Jiang, W., Reich, C. F., & Pisetsky, D. S. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00616.2005 · Cited by 538
Li, J., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16498 · Cited by 525
Targeting HMGB1 in inflammation
Yang, H., & Tracey, K. J. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.019 · Cited by 351
Cited by
Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2022.11.013 · Cited by 262
Necroptosis contributes to chronic inflammation and fibrosis in aging liver
Mohammed, S., Thadathil, N., Selvarani, R., Nicklas, E. H., Wang, D., Miller, B. F., Richardson, A., & Deepa, S. S. (2021) · Aging Cell · doi:10.1111/acel.13512 · Cited by 192
Hepatic Macrophage Responses in Inflammation, a Function of Plasticity, Heterogeneity or Both?
Zwicker, C., Bujko, A., & Scott, C. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690813 · Cited by 41
“cellular debris from dead hepatocytes (47).”
BackgroundYoon, J.-S., & Lee, C.-W. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00883-0 · Cited by 14
Emerging Roles of High-mobility Group Box-1 in Liver Disease
Wang, L., Dong, Z., Zhang, Y., & Peng, L. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00317 · Cited by 8
Metadata
- Authors
- Gaskell, H., Ge, X., & Nieto, N.
- Venue
- Hepatology Communications
- Published
- 2018-09
- Volume
- 2
- Issue
- 9
- Pages
- 1005-1020
- ISSN
- 2471-254X (ISSN-L)
- OpenAlex
- W2890644813
- Cited by
- 106
- References
- 14
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High‐Mobility Group Box‐1 and Liver Disease. https://app.cochat.ai/papers/10.1002/hep4.1223
- The paper
- Gaskell, H., Ge, X., & Nieto, N. (2018). High‐Mobility Group Box‐1 and Liver Disease. Hepatology Communications. https://doi.org/10.1002/hep4.1223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.